Hepatic Encephalopathy clinical trials

Explore recruiting hepatic encephalopathy clinical trials.

Recruiting hepatic encephalopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatic Encephalopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)

Italy, Germany, France, Poland, Spain, Hungary +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis.

Belgium, Spain, France, Germany, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction.

Hungary, Spain, Italy, Germany, Greece

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis

Netherlands, France, Norway, Hungary, Italy, Lithuania +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fecal Microbiome Transplantation in Cirrhosis. Randomized, Double-blinded, Placebo-Controlled trial in patients with decompensated cirrhosis.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection

France, Austria, Germany, Romania, Belgium, Spain +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Hepatic Encephalopathy trials by city

Hepatic Encephalopathy in Toronto Hepatic Encephalopathy in Vancouver Hepatic Encephalopathy in Montreal Hepatic Encephalopathy in Calgary Hepatic Encephalopathy in Edmonton Hepatic Encephalopathy in Ottawa Hepatic Encephalopathy in Winnipeg Hepatic Encephalopathy in Quebec City Hepatic Encephalopathy in Hamilton Hepatic Encephalopathy in Kitchener Hepatic Encephalopathy in London Hepatic Encephalopathy in Halifax Hepatic Encephalopathy in New York Hepatic Encephalopathy in Los Angeles Hepatic Encephalopathy in Chicago Hepatic Encephalopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease